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ABSTRACT* 
Background: Non-steroid anti-inflammatory drugs 
(NSAIDs) are a widely used therapeutic group in the world, 
and particularly in the Portuguese population.  
Objective: To compare NSAID’s use by prescription and 
self-medication acquisition and to determine the pattern of 
indication of NSAIDs, their usage profile and possible 
implications for patients’ safety.  
Methods: A cross-sectional design was used where 
individuals presenting at a community pharmacy 
requesting NSAIDs during the study period (one month) 
were invited to answer a face-to-face interview where 
socio-demographic characteristics, the indication pattern 
and previous experience of side effects were assessed. A 
follow-up interview was performed one week later to 
assess the incidence of adverse effects. The study was 
ethically approved.  
Results: A sample of 130 NSAIDs users was recruited, 
comprising mostly women (n=87; 66.9%), actively 
employed (n=77; 59.2%) and presenting a mean age of 
49.5 years old (SD=20.49). An equal proportion of 
individuals acquired NSAIDs by self-medication and with 
medical prescription (n=65; 50%). Over 4/5 of patients 
(n=57; 87.7%) acquiring NSAIDs without a prescription 
were self-medicated by their own initiative, and only 10.8% 
(n=7) had been advised by the pharmacist. The most 
commonly acquired active substances were ibuprofen and 
diclofenac. Self-medicated users more frequently resorted 
to topical NSAIDs following short term treatments. The 
major underlying condition motivating NSAIDs sought 
were musculoskeletal disorders (45.0%), regardless of the 
regimen. An important proportion of prevalent users of 
NSAIDs reported previous experience of adverse effects 
(11.3%). One week after initiating NSAID therapy, a small 
proportion of patients reported incidence of adverse 
effects.  
Conclusion: Self-medication with NSAIDs is sought for 
numerous medical conditions. Reported adverse effects 
(prevalent and incident) confirm the need for a more 
rational use of NSAIDs and ongoing pharmacovigilance. 
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INTRODUCTION 
Non-steroid anti-inflammatory drugs (NSAIDs) are a 
widely used therapeutic group in the world and 
particularly in the Portuguese population. This holds 
true for both prescription regimes and self-
medication.1 Culturally, there is a notion of safety or 
low risk regarding these drugs, leading to a 
widespread use of these medications for common 
clinical situations such as fever, headaches, 
dysmenorrhoea, acute pains and/or chronic 
musculoskeletal conditions.2,3  
The Portuguese law defines NSAIDs as 
prescription-only medicines (POM) or over-the-
counter drugs (OTC), depending on the active 
ingredients and/or the dosages. Portugal is primarily 
state financed, having a National Health Service, 
where prescription-only NSAIDs are co-paid in 
37%.4 Since 2005, OTC drugs are available not only 
in pharmacies but also in specialized outlets5 and 
since then, NSAID acquisitions have increased 
dramatically, becoming, in 2013, the 6th most 
acquired therapeutic group in Portugal.6 This is 
alarming, since the literature refers that in countries 
where over-the-counter NSAIDs can be acquired 
outside of pharmacies, the increase in NSAID 
consumption and the decrease in professional 
counseling (by physicians and pharmacists) may 
pose a serious risk for a substantial increase in 
adverse effect occurrences.7 Important prescription 
measures have been recently implemented, as this 
overconsumption raises health and financial 
concerns. Portugal is currently in an economic crisis 
and the population’s financial deprivation has been 
suggested to diminish physicians’ appointments8, 
which in turn may lead to higher self-medication 
rates. 
NSAID use patterns have been documented for 
various populations. In Italy, NSAID usage is 
common and more prevalent in the elderly and in 
females.9 NSAID adverse effects have been 
extensively surveyed, particularly in the last decade, 
and in high risk patients, including the elderly.10 The 
numerous factors inherent to the elderly, such as 
comorbidities and polypharmacy, as well as 
physiological changes that modify pharmacokinetics 
and pharmacodynamics, make the aged highly 
susceptible to develop drug related problems.11 
Literature supports the higher incidence of NSAID 
adverse effects in the elderly.12 A Spanish study 
conducted in the elderly determined that NSAIDs 
are among the three groups with the highest 
percentage of potentially inappropriate medication, 
especially in patients with moderate and high blood 
pressure, heart failure and chronic kidney disease.13 
The most prevalent NSAID adverse effects are 
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gastrointestinal or cardiovascular in nature10,11,13-17, 
with a prevalence of gastrointestinal adverse effects 
as high as 20%.18 Gastrointestinal NSAID adverse 
effects pose a particular challenge since they may 
occur with short term high dosage therapies 
(abdominal pain, diarrhoea), as well as long term 
low dosage therapies (intestinal or gastric ulcers 
and/or perforations).19 Although NSAIDs have been 
long used, the recent changes in the 
pharmacovigilance system suggest that ongoing 
evaluation of the usage profile of all drugs is 
extremely important, as real world tends to shift the 
indications initially approved, leading to unknown 
safety and effectiveness profiles.4 Small scale 
studies are therefore emerging, which modestly 
contribute to an in-depth knowledge of the pattern of 
use.20 
This study aims to contribute to enlighten the reality 
of NSAIDs acquisition and consumption pattern in 
Portugal and its relation with adverse effects and 
patient safety, namely to ascertain if self-medication 
is or not a risk factor for the occurrence of adverse 
reactions to these drugs. Adverse effects and self-
medication have not been studied thoroughly in 
Portugal, thus studies in this field are of great 
importance.  
This study aimed to compare NSAIDs acquired by 
prescription and self-medication regarding its 
indication, route of administration, treatment 
duration, reported adverse effects and socio-
demographic profile of individuals. The study also 
aimed to ascertain how previous experience of side 
effects to NSAIDs influenced the acquisition pattern. 
 
METHODS  
An observational descriptive cross-sectional study 
was undertaken, with information being collected for 
each individual at one moment in time.21 The 
information collected in this moment referred to 
present and past exposure. There was a subsample 
being re-evaluated after one week of exposure, 
constituting an exposure cohort. Recruitment of 
individuals was pursued over a one month period 
(August 2013) in one community pharmacy. 
Population and sample 
Sample size was estimated using Epi Info, version 
7, considering the population served by each 
community pharmacy in Portugal, defined by law to 
be 3500 inhabitants22, a prevalence of NSAIDs use 
in the general population of 19.4%23 and a 
confidence interval of 95% (CI=95%). The 
estimation was for 384 participants. However, we 
have assumed that pharmacy users may visit the 
pharmacy every three months. Since the study 
could only last one month, we should be able to 
recruit 128 individuals.  
Sampling was non-random, as one single pharmacy 
was chosen by feasibility issues (convenience 
sample), where the pre-registration student was in 
charge of patient recruitment between 10 am and 
10 pm. All individuals entering the pharmacy during 
the study period were invited to participate in the 
study, constituting an exhaustive sample. 
One single inclusion criterion was considered, 
demonstrating intention to acquire an NSAID for 
himself/herself or for a minor under his/hers 
responsibility, with or without prescription. Exclusion 
criteria considered were inability to communicate in 
Portuguese and/or English, especially by language 
barriers; evident cognitive impairment or refusal to 
participate in the study. 
Data collection 
A structured questionnaire was developed to be 
administered face-to-face to patients, and filled in by 
the main researcher, which was divided into 8 
sections: 
1. Socio-demographic characterization (e.g. age, 
gender, civil status, educational level and 
professional situation); 
2. Therapeutic classification: active substance, 
dosage, pharmaceutical form, package 
dimension, frequency of use, duration of therapy 
and route of administration; 
3. Reason for purchasing the drug: indication 
(complaint leading to the need of drug); 
4. Person who identified the need for such therapy 
(prescription-based or self-medication); 
5. Previous exposure to NSAIDs; 
6. Legal classification of the NSAID purchased: 
non-prescription medicine or prescription only; 
7. Concurrent medications taken; 
8. History of previous adverse effects to NSAIDs. 
Patients were grouped in either the Prescription 
group or the Self-Medication group. All situations 
where the patient did not have a prescription at the 
moment of purchase were considered ‘self-
medication’. Patients whose symptoms guided the 
pharmacist to advice using an NSAID, and those 
acquiring an NSAID solely on the basis of their will, 
were also considered self-medicating patients. 
Patients were classified as first-time users if they 
had never been exposed to an NSAID or prevalent 
users if there was previous exposure.  
One week after the NSAID acquisition, patients 
were asked by telephone to answer a second 
questionnaire to evaluate possible adverse effects 
arising from NSAID exposure. 
Data analysis 
Data was analysed using SPSS (IBM SPSS 
Statistics for Windows, Version 21.0. Armonk, NY: 
IBM Corp) and included tests to answer research 
questions posed. We used parametric tests, once 
normality distribution was verified (Kolmogorov-
Sminorf Test), namely the Student’s t-test and the 
Chi-square or Fisher, as appropriate, considering a 
significance level of 0.05. The research questions 
were: 
1. Do socio-demographic characteristics influence 
self-medication with NSAIDs?  
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2. Are the pharmacotherapeutic groups of NSAIDs 
determinants of self-medication?  
3. Does the legal classification of medicines 
determine practice? 
4. Does the route of administration and treatment 
duration influence self-medication? 
5. Is previous exposure to NSAID a determinant of 
self-medication? 
6. Are the presenting conditions determinants of 
self-medication with NSAIDs?  
7. What are the most common drugs taken 
simultaneously with NSAIDs that have potential 
interactions?  
8. Does previous experience of adverse effects 
with NSAIDs influence self-medication?  
9. The incidence of adverse effects with NSAIDs is 
higher in those previously experiencing adverse 
effects? 
Outcome measures 
The main outcomes considered were previous 
exposure to adverse effects and incidence of 
adverse effects.  
Ethical approval 
The study protocol was approved by the Ethics 
committee of the Institute of Health Sciences Egas 
Moniz. Non-participants were not characterized as 
this committee rejected the possibility to use refusal 
forms. 
 
RESULTS  
Socio-demographic characterization of the 
population 
The initial sample was constituted by 159 
individuals, where 29 have been excluded because 
they were using low dose acetylsalysilic acid 
formulations (dosage equal or below 300 mg), for 
which the indication is not anti-inflammatory but 
antiplatelet forming.  
From the final sample of 130 individuals, the 
majority were female (n=87; 66.9%). The mean age 
of study recruits was of 49.46 years old (SD=20.49), 
ranging from 3 to 87 years old. Most participants 
were married (n=72; 55.4%), employed (n=77; 
59.2%) and with high school education or lower 
(n=89; 68.5%).  
Characterization and comparison of the socio-
demographic profiles for prescription and self-
medication regimens 
Table 1 summarizes the differences in socio-
demographic profiles between patients who 
acquired NSAIDs with a prescription and those that 
self-medicated, with the same number of individuals 
in each group (n=65). No characteristics were found 
to be associated with the option to acquire under 
medical supervision or under self-medication 
(p>0.05 for all variables).  
Distribution of NSAIDs acquired by chemical 
group 
Propionic acid derivatives were the most requested 
NSAID (n=63; 48.5%), followed by acetic acid 
derivatives (n=29; 22.3%), and sulfonanilides 
derivatives (n=17; 13.1%), as depicted in table 2.  
More than half of prescriptions were for propionic 
acid derivatives (n=41; 63.1%), which were also 
predominant for self-medications (n=22; 33.8%). 
However, the prescription group evidenced a higher 
rate of acetic acid derivatives (n=10; 15.4%) and 
COX-2 selective inhibitors (n=8; 12.3%), suggesting 
that the pharmacotherapeutic group is a 
determinant of self-medication (p<0.005). 
Legal classification of purchased NSAIDs 
Most NSAIDs acquired were prescription-only 
NSAIDs (n=106; 81.5%), representing more than 
three quarters of all NSAIDs purchased. Most of 
these were acquired with a prescription (n=61; 
57.5%), but a still considerable proportion did so 
without presenting a prescription (n=45; 42.5%). For 
over-the-counter NSAIDs, most of them were 
acquired under self-medication, (n=20; 83.3%), with 
only 4 of them being prescribed (16.7%). The vast 
majority of prescribed NSAIDs (93.8%) were legally 
classified as prescription-only, whereas 45% of 
purchased NSAIDs without prescription were also 
prescription-only. These findings suggest that 
although regulations in place are not strictly 
followed, there is a tendency to obey the law 
(p<0.001) (Table 2). 
Route of administration and treatment duration 
Most NSAIDs purchased during the study period 
were to be administered orally, both in the 
prescription and in the self-medication group (n=58; 
Table 1. Comparison of the socio-demographic profiles for prescription and self-medication regimens. 
Variable Category Total Prescription Self-medication p-value n (%) n (%) n (%) 
Gender Male 43 (33.1) 23 (35.4) 20 (30.8) 0.576a Female 87 (66.9) 42 (64.6) 45 (69.2) 
Civil state Married 72 (55.4) 34 (52.3) 38 (58.5) 0.480a Unmarried 58 (44.6) 31 (47.7) 27 (41.5) 
Academic status 
Illiterate 6 (4.6) 2 (3.1) 4 (6.2) 
0.816b High school or lower 89 (68.5) 45 (69.2) 44 (67.7) 
University degree 35 (26.9) 18 (27.7) 17 (26.2) 
Professional situation Active 77 (59.2) 38 (58.5) 39 (60.0) 0.858a Not active 53 (40.8) 27 (41.5) 26 (40.0) 
n - number of individuals in the group, (%) - percentage, p - statistical significance, a Chi-square test, b Fisher's exact 
test. 
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89.2% and n=48; 73.8%, respectively), followed by 
topical NSAIDs (n=5; 7.7% and n=17; 26.2%). 
Intramuscular NSAIDs were exclusively acquired 
with prescription. These findings are somehow 
consistent with the results formerly presented as all 
intra-muscular NSAIDs are prescription-only 
medicines, whereas most topical ones as classified 
as OTC medicines (Table 3).  
The duration of treatment was classified considering 
short-term treatment to be less than 1 week, 
medium-term between 1 and 4 weeks and long term 
any treatment lasting over 1 month, suggesting 
chronic use. Short-term was the most commonly 
found treatment in both regimens, being slightly 
more frequent in self-medicated patients (n=53; 
81.5% vs n=39; 60.0%). Most medium-term 
treatments were acquired with prescription and 
long-time treatments showed approximately the 
same proportion in both groups (Table 3). Data 
suggests that both the route of administration and 
treatment duration are associated with NSAID self-
medication (p<0.001). 
Previous exposure to NSAIDs 
Most patients were classified as prevalent users 
(n=109; 83.7%), among which only 56.0% were 
included in the self-medication group (n=61). 
Twenty one patients were incident users (16.2%), 
the majority of whom were purchasing a prescribed 
medicine (n=17; 81.0%). Data indicates that these 
variables are associated, suggesting self-
medication may occur when previous experience 
has been obtained following medical indication 
(p=0.002). 
Among prevalent users, most of them were 
acquiring the NSAID according to their own will and 
judgment (n=56; 91.8%), while most incident 
patients were acquiring the NSAID due to advise 
from the pharmacist (n=3; 75%). The majority of 
self-medicating patients (93.8%) was a prevalent 
user, which suggests that previous exposure to an 
NSAID leads to a higher probability of self-
medication (p=0.005). 
Presenting conditions for purchasing NSAIDs  
The most common presenting condition was 
musculoskeletal disorders (n=58; 45.0%), with an 
homogenous distribution between cases of 
prescription and self-medication. Prescription 
patients presented an important representation of 
toothache situations (n=11; 17.2%). All kidney 
disease patients acquired the NSAID presenting a 
prescription. There was a high representation of 
acute pain and/or inflammatory states in self-
medication (n=17; 26.2%), followed by flu-like 
diseases, feverish diseases and upper airways/ear 
infections (n=16; 24.6%), as well as acquisitions to 
have a “stock” of the NSAID at home (n=2; 3.1%). 
Data suggests that the presenting condition 
influences self-medication (p=0.010) (Figure 1). 
Polypharmacy and potential interactions  
Most patients acquiring NSAIDs were 
simultaneously taking other therapeutic classes 
(n=75; 57.7%), in even proportion between 
prescription and self-medicating patients (p>0.05). 
The most commonly found pharmacotherapeutic 
groups taken simultaneously were antihypertensive 
Table 2. Distribution of NSAIDs chemical groups in prescription and self-medicated patients. 
Chemical group Drugs Legal classification in Portugal 
Acquisition regimen 
Self-
medication Prescription 
Salicylates Acetylsalicylic acid 500mg OTC 7  0 
COX2 selective inhibitors Celecoxib 200 mg Etoricoxib 60mg, 90mg 
POM 
POM 
0 
1 
2 
6 
Propionic acid derivatives 
Ibuprofen 200mg 
Ibuprofen 200mg/ml 
Ibuprofen 400mg, 600mg 
Naproxen 250mg, 500mg 
Cetoprofen 100mg 
Cetoprofen 100mg/2ml 
Picetoprofen 18mg/g, 20 mg/g 
Dexcetoprofen 400mg 
OTC 
OTC 
POM 
POM 
POM 
POM 
POM  
POM 
2 
5 
11 
0 
0 
0 
4 
0 
0 
3 
25 
8 
1 
1 
1 
2 
Acetic acid derivatives 
Diclofenac 50mg, 100 mg 
Diclofenac 75mg/3ml 
Diclofenac 10mg/g, 23.2mg/g, 
0.074% 
POM 
POM 
OTC 
8 
0 
11 
5 
1 
4 
Oxicam derivatives Meloxicam 15mg POM 0 2 
Sulfonanilides derivatives Nimesulide 100mg POM 14 3 
Anthranilic acid derivatives Etofenamate 100mg/ml POM 2 0 
POM = Prescription only medicines; OTC= Over-the-counter 
Table 3. Route of administration and treatment duration in prescription and self-medication regimens 
Variable Categories Total Prescription Self-medication p-value n (%) n (%) n (%) 
Route of 
administration 
Oral 106 (81.5) 58 (89.2) 48 (73.8) 
0.005a Topical 22 (17.0) 5 (7.7) 17 (26.2) 
Intramuscular 2 (1.5) 2 (3.1) 0 (0.0) 
Treatment 
duration 
Short term 92 (71.3) 39 (60.0) 53 (81.5) 
0.005a Medium term 21 (16.3) 17 (26.2) 4 (6.2) 
Long term 16 (12.4) 9 (13.8) 8 (12.3) 
n - number of individuals in the group, (%) - percentage, p - statistical significance, a Fisher's exact test. 
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drugs (n=38), followed by lipid-lowering drugs 
(n=17), oral anti-diabetic drugs (n=12), anxiolytic 
drugs (n=15) anti-acid/anti-ulcer drugs (n=11), oral 
contraceptives (n=8) and antidepressant drugs 
(n=7). Worth noting that many of these therapeutic 
groups have drug-drug interactions with NSAIDs 
described in the literature.  
Six patients (4.6%) were taking two NSAIDs 
simultaneously: naproxen and celecoxib; ibuprofen 
and eterocoxib; picetoprofen and diclofenac; 
picetoprofen and flubiprofen; eterocoxib and 
diclofenac; and dual diclofenac, suggesting 
irrational drug use. 
Characterization of previous side effects 
There was a prevalence of 13.1% patients reporting 
previous adverse effects to NSAIDs (n=17), where 2 
patients reported previous side effects to more than 
one NSAID. Table 4 displays the number of patients 
in the sample taking the medicine at the time of 
study (N) and those previously experiencing 
adverse effects with that same medicine (n), not 
necessarily the same patient.  
The frequency of side effects shows that more than 
half of all effects were under the form of dyspepsia 
(table 4). Each adverse effect was distributed by the 
NSAID that self-reportedly provoked it. Increased 
blood pressure cases were associated with 
etoricoxib. Constipation was associated with 
naproxen, nausea and vomiting with ibuprofen, 
dyspnea with piroxicam, hypersensitivity with 
ibuprofen, diclofenac and acetilsalylic acid. 
Abdominal pain was associated with diclofenac 
(n=2), nimesulide (n=1), etorocoxib (n=1) and 
ibuprofen (n=5). 
The proportion of patients experiencing previous 
side-effects was evenly distributed between 
prescription and self-medication, suggesting these 
two phenomena to be independent (p>0.05).  
One week after NSAIDs acquisition, from the initial 
159 patients, only 31 answered the second 
questionnaire, invalidating bivariate analysis. From 
these 31 patients, only 3 reported adverse effects 
(9.7%). The drugs involved were ibuprofen and 
nimesulide purchased as self-medication (n=2) 
which caused stomach pain in both patients, and 
prescribed etoricoxib (n=1) which was associated 
with high blood pressure. All 3 patients had already 
previously reported adverse effects to NSAIDs and 
the patient taking etoricoxib had previously suffered 
from high blood pressure with the same drug. This 
data suggests patients with previous experience of 
adverse effects may be at higher risk of developing 
new and repeated adverse effects.  
 
Table 4. Absolute and relative frequencies of drug 
that previously caused adverse effects and 
description of side effects. 
NSAID N n
Ibuprofen 46 7
Diclofenac 32 3
Nimesulide 18 1
Naproxen 9 1
Etoricoxib 8 3
Acetylsalicylic acid 7 1
Piroxicam 0 1
Total 130 17 
   
Side effects n (%) 
Dyspepsia 9 52.9 
Hypersensitivity 3 17.6 
High blood pressure 2 11.8 
Constipation 1 5.9 
Nausea and vomiting 1 5.9 
Dyspnea 1 5.9 
Total 17 100.0 
Figure 1. Reasons for NSAID purchase in prescribed and self-medication regimens. 
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DISCUSSION 
Previous studies confirm our findings that NSAIDs 
are mostly sought by young active married 
females.9,24,25  
NSAIDs were evenly acquired upon presentation of 
a medical prescription and by self-medication 
(50%), consistent with a previous Italian study9, but 
double from the reported in the Portuguese urban 
population.26 However, it should be noticed that the 
latter study did not focus on NSAIDs specifically but 
rather on the overall self-medication pattern. 
Additionally, one may consider that the present 
financial crisis Portugal is facing could impact on 
self-medication as Mendes et al. have pointed that 
individuals who seek the Portuguese National 
Health Service (PNHS), as opposed to private 
health services, display a higher tendency for self-
medication.26 The increase in moderating fees 
recently witnessed in Portugal, may have 
conditioned access to PHNS and indirectly led to an 
increase in self-medication. Moderating fees have 
been introduced in the PNHS in 1986, imbedded in 
the 2nd revision of the Constitution. These represent 
direct partial payments and are referred to as 
“mainly free health service”. These are payments 
the citizens make when they use the services and 
values differ according to the type of service; they 
exist for citizens to refrain from abusing the service. 
Pain was self-reportedly the main reason for 
acquiring NSAIDs in this study, which is in line with 
previous studies.9 Data suggests that acute, painful 
states are associated with self-medication. This 
finding may have safety implications as it was 
suggested that among patients seeking NSAIDs 
following musculoskeletal complaints, 6% incur in 
adverse events.27 
Prescription-only represent the majority of 
purchased NSAIDs, but an important proportion of 
self-medicating patients acquired prescription-only 
medicines, which is a worrisome finding. Although 
prescription-only medicines can only be purchased 
when presenting a medical prescription, as the 
functioning of the health care system leads to long 
waiting time for medical appointments. This may 
create a dilemma between blindly obeying the law 
and deprive the patient from needed therapy or 
dispense the medicine ahead of prescription, where 
the patient assumes the compromise to present it 
later. However, creating exceptions may lead 
pharmacists to fall into situations of malpractice, 
when clinical judgment is not correctly applied. Even 
though this malpractice is not properly documented 
in the literature, it certainly exists in Portugal, as it 
does in other countries, such as Brazil and Spain, 
two culturally similar countries.23,28 However, it 
should be noted that in such situations, it would be 
even more important for the pharmacist to intervene 
in the interest of patient safety, namely by ensuring 
there were no previous side-effects, that other 
medicines taken simultaneously do not interact, and 
that if the therapy is indeed to be prolonged, 
perhaps it would be appropriate to evaluate if the 
patient may be considered at high risk of 
gastrointestinal bleeding, needing additional 
gastroprotection.  
Low health literacy or the idea of the ineffectiveness 
of certain doses not subject to medical prescription, 
allied to poor pharmacist’s counseling are probably 
playing a significant role in the phenomenon of self-
medication with prescription-only NSAIDs. However, 
it should be noted that all medicines purchased 
without a prescription were considered as self-
medication cases. This is a methodological option 
that may be discussed as in some cases, patients 
were purchasing a medicine following the doctor’s 
recommendation (e.g. to be taken for 1 month and 
the package lasted only 15 days or recommended 
over the phone, etc) and simply not having the 
physical prescription at the moment. This fact 
assumes higher importance when analyzing 
pediatric formulations. Nonetheless, the effects of 
this practice on patient safety should be considered, 
as the safety profile is the main reason determining 
the legal classification of medicines.  
Another point that should be considered is the 
inclusion of children in the study population, as the 
therapeutic options for them available on the market 
are scarce. In fact, currently, only paracetamol and 
ibuprofen exist in pediatric formulations (both as 
prescription-only and as OTC), which may have 
skewed results presented. However, analysis was 
performed excluding children and proportions 
reported did not differ significantly. Therefore, the 
authors opted to include children. This option is also 
justified because data on safety and effectiveness 
profile of NSAID use in children are scarce. 
Although we could not study this sub-sample in 
depth, due to its limited size, the high exposure to 
ibuprofen was consistent with international data, 
which suggests a possible association with asthma 
exacerbation.29 Given the safety implications, in 
future studies, we may want to address this topic 
using a different study design.  
The vast majority of self-medicated patients 
adopted such behaviour by their own initiative. A 
small proportion of the sample was classified as 
incident users, and the majority of these cases 
occurred on prescription regimes. Still, it is worth 
noting that there were 4 cases of self-medicating 
incident users. This reinforces the notion that prior 
experiences are a key factor in self-medication for 
NSAIDs and emphasizes the role of the pharmacist, 
who should advice patients about the most 
appropriate therapy in light of their current clinical 
status and present comorbidities.30,31 
The pharmacotherapeutic group was associated 
with self-medication, where an important proportion 
opted for propionic acid derivatives, probably due to 
the safety illusion associated with this class, which 
needs to be addressed in the general population by 
more active information campaigns.  
In self-medication, there was a small number of 
medium termed treatments, probably because when 
symptoms show themselves persistent, the patient 
has a tendency to go visit a physician. The 
somewhat high number of self-medication cases for 
long term treatments can be justified by the small 
price difference resulting from a low co-payment 
attributed by the PNHS when presenting a 
prescription. On the other hand, the national 
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economic conjecture coupled with the increase of 
user fees can help to explain many situations of 
ongoing treatments that do not present a 
prescription at the time of purchase.  
In addition to these factors, the poor information 
provided by the physician and/or pharmacist about 
the duration of treatment may induce the patient to 
assume continuity of treatment, an aspect with 
potential impact on patient safety that should be 
more closely monitored by responsible bodies for 
observing compliance with best standards of 
practice. This should be a concern since the 
literature suggests that over 20% of OTC NSAID 
users prolong treatment duration for over 7 days.32 
The Portuguese Pharmaceutical Society, through 
their statutes, foresees as an important role of the 
pharmacist, ensuring rational use of medicines. All 
pharmacists do this, but the degree in which they 
actively engage in advanced services, most of 
which demand an updated pharmacotherapeutic 
profile, is variable. There are studies suggesting 
that only 20% of community pharmacies are 
providers of pharmaceutical care.33 This suggests 
there are missed opportunities for pharmacists.  
The route of administration was associated with 
self-medication. Physicians seem to prefer 
prescribing oral NSAIDs, whilst self-medicated 
patients exhibited a tendency for topical NSAIDs. 
Although this observation may also be related with 
the legal classification, it should be noted that it has 
been documented that topical NSAIDs display the 
same efficacy in certain musculoskeletal 
pathologies as oral NSAIDs, and yet display 
considerably less side effects.34-37  
The wide spectrum of NSAID use, coupled with the 
evidenced established here that self-medications 
are mostly based on previous experiences, point 
toward a collective medical responsibility in 
prescription. Whenever a health professional 
advises or prescribes a medication, he/she must be 
aware not only of the present situation, but must 
also be aware of the future. Whenever a patient 
encounters a new medication, this event must be 
seen as a new opportunity for the establishment of 
new self-medication habits. In the future, NSAID 
prescription/advising should be addressed by health 
professionals to foster a more rational use of 
medicines. 
Prevalent adverse reactions 
The prevalence of adverse reactions from previous 
exposures was 11.3%, with 3 main NSAIDs 
involved, ibuprofen, diclofenac and etoricoxib. 
Gastric complications represented 52.9% of 
adverse reactions reported in this study, a much 
higher value than the 20% reported elsewhere18,38, 
being dyspepsia, abdominal pain and diarrhoea 
those considered more common. Adverse 
gastrointestinal effects are classified as a very 
common effect in most package inserts, which 
means that they are likely to occur in more than 
10% of subjects exposed.1 Hypersensitivity was the 
second most self-reported manifestation, followed 
by increased blood pressure. The prevalence of 
hypersensitivity (including dyspnea) to NSAIDs in 
the population is 2.5%, which may be greater in 
patients with certain pathologies (chronic rash, 
nasal polyps and asthma).39 The two cases of 
elevated blood pressure were associated with 
etoricoxib, an effect described in the product 
characteristics as common, i.e., occurring between 
1-10%.40 Although the small power of this study 
leads to careful interpretation of the findings, data 
suggests the known safety profile of NSAIDs may 
be shifted by real-life situations, such as off label 
use, polypharmacy or even patients’ characteristics. 
Incident adverse reactions 
Less than 10% of the telephone surveyed patients 
reported having experienced a new adverse 
reaction to the drug taken at the time of study (n=3; 
9.7%). This value is more in line with the literature. 
However, it should be noted that this subsample 
was very reduced to draw any valid conclusions. 
However, it is important to note that the 3 patients 
experiencing adverse effects had previously 
reported adverse effects with other NSAIDs, or even 
with the same drug, suggesting irrational use of 
medicines. 
Limitations 
This study, although reporting important information, 
presents some important limitations, namely the fact 
that it portraits a study undertaken in one single 
pharmacy, making extrapolations invalid. However, 
it should be noted that the general characteristics of 
the sample are in line with national data.41 All data 
collected about experience of adverse effects was 
retrospective, favouring recall bias. Information was 
collected by a pre-registration pharmacist, leading 
to a potential social desirability bias. On the other 
hand, because the researcher was not familiar with 
regular clients, the probability of bias was 
minimized, including selection bias.41 The 
inexperience of the main researcher also had the 
downside of not taking these opportunities where 
adverse effects have been identified to actively 
engage in pharmacovigilance, by notifying the 
competent authorities. Perhaps the most important 
limitation was the inability to include a larger sample 
in the prospective evaluation of incident adverse 
effects, which limited the in-depth analysis of the 
findings. This issue should be more carefully 
planned in future studies. This study did not focus 
on pharmacists’ interventions. However, it will be 
interesting in the future to use our results to develop 
specific training for community pharmacists to more 
actively engage in interventions aimed at increasing 
NSAIDs users’ safety, particularly if targeted at 
patients with high risk of upper gastrointestinal 
complications, namely the elderly.42 
Self-medicated patients displayed good choices of 
active substances for their conditions, as well a 
general good sense for frequency of use. Still, the 
widespread use of NSAIDs, whether with a 
prescription or through self-medication, is leading to 
an illusion of safety of these drugs in the population. 
Polypharmacy and the presence of comorbidities 
need to be thoroughly addressed by all health 
professionals whenever they are prescribing or 
advising NSAIDs, as it was found that self-
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medication is used in numerous medical conditions. 
This information should help shape future public 
health campaigns and advanced pharmaceutical 
interventions for a more rational use of NSAIDs. 
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